✦ LIBER ✦

Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

✍ Scribed by J. P. Maroto, X. G. del Muro, B. Mellado…

Book ID: 120902395
Publisher: Springer Milan
Year: 2013
Tongue: Spanish
Weight: 338 KB
Volume: 15
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-012-0991-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of interferon alpha-2A

A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma

✍ Brian R. Murphy; Susan M. Rynard; Lawrence H. Einhorn; Patrick J. Loehrer 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 499 KB

Sequential administration of interferon

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Phase II Study of Interferon-gamma Versu

Phase II Study of Interferon-gamma Versus Interleukin-2 and Interferon-alpha 2b in Metastatic Renal Cell Carcinoma

✍ Lummen, Gerd; Goepel, Mark; Mollhoff, Stefan; Hinke, Axel; Otto, Thomas; Rubben, 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 476 KB

A phase II study of interferon α and low

A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

Subcutaneous interleukin-2, interferon a

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

✍ Ravaud, A; Trufflandier, N; Ferrière, J M; Debled, M; Palussière, J; Cany, L; Ga 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

795 ORAL Phase II trial of sorafenib (BA

795 ORAL Phase II trial of sorafenib (BAY 43–9006) in combination with interferon alpha 2b in patients with metastatic renal cell carcinoma

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 273 KB